- Record: found
- Abstract: not found
- Article: not found
Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis.
2007-02-28
Clinical Trials as Topic, Contrast Media, adverse effects, Evidence-Based Medicine, Fibrosis, Gadolinium, diagnostic use, Humans, Incidence, Kidney Failure, Chronic, chemically induced, epidemiology, Magnetic Resonance Imaging, statistics & numerical data, Risk Assessment, methods, Risk Factors, Skin, pathology, Skin Diseases
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Clinical Trials as Topic,Contrast Media,adverse effects,Evidence-Based Medicine,Fibrosis,Gadolinium,diagnostic use,Humans,Incidence,Kidney Failure, Chronic,chemically induced,epidemiology,Magnetic Resonance Imaging,statistics & numerical data,Risk Assessment,methods,Risk Factors,Skin,pathology,Skin Diseases
Clinical Trials as Topic, Contrast Media, adverse effects, Evidence-Based Medicine, Fibrosis, Gadolinium, diagnostic use, Humans, Incidence, Kidney Failure, Chronic, chemically induced, epidemiology, Magnetic Resonance Imaging, statistics & numerical data, Risk Assessment, methods, Risk Factors, Skin, pathology, Skin Diseases